key: cord-0750433-7fe2vdm7
authors: Kotwa, J. D.; Jamal, A. J.; Mbareche, H.; Yip, L.; Aftanas, P.; Barati, S.; Bell, N. G.; Bryce, E.; Coomes, E. D.; Crowl, G.; Duchaine, C.; Faheem, A.; Farooqi, L.; Hiebert, R.; Katz, K.; Khan, S.; Kozak, R.; Li, A. X.; Mistry, H. P.; Mozafarihashjin, M.; Nasir, J. A.; Nirmalarajah, K.; Panousis, E.; Paterson, A.; Plenderleith, S.; Powis, J.; Prost, K.; Schryer, R.; Taylor, M.; Veillette, M.; Wong, T.; Zhong, X. Z.; McArthur, A. G.; McGeer, A. J.; Mubareka, S.
title: Surface and air contamination with SARS-CoV-2 from hospitalized COVID-19 patients in Toronto, Canada
date: 2021-05-20
journal: nan
DOI: 10.1101/2021.05.17.21257122
sha: 4a9b191490b4dfe8e3d53b26fd552486aca7c91c
doc_id: 750433
cord_uid: 7fe2vdm7

Background The aim of this prospective cohort study was to determine the burden of SARS-CoV-2 in air and on surfaces in rooms of patients hospitalized with COVID-19, and to identify patient characteristics associated with SARS-CoV-2 environmental contamination. Methods Nasopharyngeal swabs, surface, and air samples were collected from the rooms of 78 inpatients with COVID-19 at six acute care hospitals in Toronto from March to May 2020. Samples were tested for SARS-CoV-2 viral RNA and cultured to determine potential infectivity. Whole viral genomes were sequenced from nasopharyngeal and surface samples. Association between patient factors and detection of SARS-CoV-2 RNA in surface samples were investigated using a mixed-effects logistic regression model. Findings SARS-CoV-2 RNA was detected from surfaces (125/474 samples; 42/78 patients) and air (3/146 samples; 3/45 patients) in COVID-19 patient rooms; 14% (6/42) of surface samples from three patients yielded viable virus. Viral sequences from nasopharyngeal and surface samples clustered by patient. Multivariable analysis indicated hypoxia at admission, a PCR-positive nasopharyngeal swab with a cycle threshold of [≤]30 on or after surface sampling date, higher Charlson co-morbidity score, and shorter time from onset of illness to sample date were significantly associated with detection of SARS-CoV-2 RNA in surface samples. Interpretation The infrequent recovery of infectious SARS-CoV-2 virus from the environment suggests that the risk to healthcare workers from air and near-patient surfaces in acute care hospital wards is likely limited. Surface contamination was greater when patients were earlier in their course of illness and in those with hypoxia, multiple co-morbidities, and higher SARS-CoV-2 RNA concentration in NP swabs. Our results suggest that, while early detection and isolation of COVID-19 patients is important, air and surfaces may pose limited risk a few days after admission to acute care hospitals.

SARS-CoV-2 RNA was detected from surfaces (125/474 samples; 42/78 patients) and air (3/ 146 samples; 3/45 patients) in COVID-19 patient rooms; 14% (6/42) of surface samples from three patients yielded viable virus. Viral sequences from nasopharyngeal and surface samples clustered by patient.

Multivariable analysis indicated hypoxia at admission, a PCR-positive nasopharyngeal swab with a cycle threshold of ≤ 30 on or after surface sampling date, higher Charlson co-morbidity score, and shorter time from onset of illness to sample date were significantly associated with detection of SARS-CoV-2 RNA in surface samples.

The infrequent recovery of infectious SARS-CoV-2 virus from the environment suggests that the risk to healthcare workers from air and near-patient surfaces in acute care hospital wards is likely limited.

Surface contamination was greater when patients were earlier in their course of illness and in those with hypoxia, multiple co-morbidities, and higher SARS-CoV-2 RNA concentration in NP swabs. Our results suggest that air and surfaces may pose limited risk a few days after admission to acute care hospitals.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 causing the coronavirus disease 2019 (COVID-19) pandemic 1 and many hospital outbreaks of COVID- 19. 2 Understanding the role of surface and air (environmental) contamination in the transmission of SARS-CoV-2 is essential to ensuring the prevention of transmission of SARS-CoV-2 between patients and to healthcare workers in acute care hospitals.

SARS-CoV-2 RNA has been detected from surfaces and air in hospitals. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] However, a minority of studies have attempted to culture virus. 13, 14 This limits our understanding of exposure and transmission risk.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 20, 2021. ;  https://doi.org/10.1101/2021.05.17.21257122 doi: medRxiv preprint SARS-CoV-2 whole-genome sequencing has been used to determine the extent of community transmission and inform public health intervention. 15 While whole-genome sequences are generally obtained through upper respiratory samples such as nasopharyngeal (NP) swabs, [16] [17] [18] applying a genomics approach to environmental samples for SARS-CoV-2 may confirm sources of environmental contamination and potentially identify transmission bottlenecks and determinants of environmental persistence.

This study aimed to determine the burden of SARS-CoV-2 in the air and on surfaces in hospital rooms of acutely ill inpatients with COVID-19 in Toronto, Ontario, Canada. We also compared SARS-CoV-2 whole-genome viral sequences from patient nasopharyngeal swabs and surfaces in their rooms and determined the association between patient factors and detection of SARS-CoV-2 from environmental samples.

The Toronto Invasive Bacterial Diseases Network (TIBDN) performs population-based surveillance for infectious diseases in metropolitan Toronto and the regional Municipality of Peel, south-central Ontario, 

Demographic, clinical, and COVID-19 risk factor data were collected by participant interview and chart review. Study staff obtained NP swabs from patients at enrollment and every three days until refusal, hospital discharge, or death. 20 A set of surface samples was collected at enrollment and every three days, including: 1) bathroom doorknob, 2) phone (all surfaces of the patient's phone and room phone), 3) overbed table and chair (pooled), 4) bed (bed rail and pillow) and light switch or pullcord in patient's bedspace (pooled), and 5) toilet and sink faucet handles (pooled) (Supplementary Figure 1) . Surface samples were collected by thoroughly wiping each surface type using the rough side of a dry 6 cm x 6 cm Swiffer cloth (Swiffer®, Procter & Gamble, Toronto, Canada). Nasopharyngeal swabs and Swiffer cloths were immediately placed into universal transport medium (UTM; Copan Diagnostics, Murrietta, CA).

During the study period, four bioaerosol samplers were used for sampling the first 45 patients enrolled that were not intubated. For each patient, one to two different bioaerosol samplers were used in each run.

Using an air sampling pump (GilAir Plus Personal Air Sampling Pump, Sensidyne, St. Petersburg, FA), air samples were obtained using the 1 μ m pore size, 37 mm polytetrafluoroethylene (PTFE) membrane filters (SKC Inc, Eighty Four, PA), the 37 mm three-piece cassette with 0·8 μ m polycarbonate (PC) filter (Zefon International, Ocala, FA), and 25 mm gelatin membrane filters (SKC Inc, Eighty Four, PA). Prior to sampling, the pumps were calibrated to a flow rate of 3·5 L/min using the corresponding filter used for sampling that day (Gilibrator 3, Standard Flow Dry Cell Calibrator, Sensidyne, St. Petersburg, FA). In the patient rooms, samplers were placed at 1 m and 2 m from the patient at the level of the bed and samples were collected over a 2 h period. All filters were placed in coolers at the end of the sampling period for transport and processed immediately. Air samples were also collected using the NIOSH two-stage cyclone bioaerosol sampler (National Institute for Occupational Safety and Health, Morgantown, WV).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The NIOSH cyclone bioaerosol sampler is comprised of stages collecting larger particles (>4 μ m) in the first stage into 15 mL conical tubes, smaller particles (1) (2) (3) (4) μ m) in the second stage into 1·5 mL conical tubes, and particles <1 μ m onto a PTFE filter. The NIOSH cyclone samplers were assembled in the laboratory in a biosafety cabinet and calibrated to a flow rate of 3.5 L/min (BIOS DC-1 DryCal flow calibrator, SKC Inc, Eighty-Four, PA). In the patient rooms, the sampler was placed 1m from the patient and sampling occurred over a 2 h period.

All samples were processed at Sunnybrook Research Institute on the day of collection. Nasopharyngeal swabs and environmental samples were vortexed for 20 s before aliquoting and storage at -80°C. PTFE, PC, and gelatin membrane filters were placed in 3 ml transport media before being vortexed for 20s, followed by aliquoting and storage at -80°C. For the NIOSH cyclone bioaerosol sampler, 1 mL of transport media was added to the first stage, 500 μ L to the second stage, and 3 mL of transport media were aliquoted onto the PTFE filter. Samples were vortexed for 20 s before aliquoting and storage at -80°C. RNA extractions were performed using QIAmp viral RNA mini kit (Qiagen, https://www.qiagen.com) according to manufacturer's instructions; samples were eluted into 40 uL.

Reverse-transcriptase polymerase chain reaction (RT-PCR) reactions were performed using the Luna Universal Probe One-Step RT-qPCR Kit (New England BioLabs Inc, https://www.international.neb.com).

Two separate gene targets were used for detection of SARS-CoV-2, the 5' untranslated region (UTR) and the envelope (E) gene, with human RNaseP as an internal control. 21 The cycling conditions were: 1 cycle of denaturation at 60 °C for 10 min then 95 °C for 2 min followed by 44 amplification cycles of 95°C for 10 s and 60°C for 15 s. Rotor-Gene Q software (Qiagen, https://www.qiagen.com) was used to determine cycle thresholds (Ct) and samples with Cts <40 in both UTR and E genes were considered positive.

Correlation analysis indicates almost perfect correlation between Ct values for the UTR and E gene (0·99). We therefore present Ct values for the UTR gene target within the text; the Ct value results for . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 20, 2021. ; https://doi.org/10.1101/2021.05.17.21257122 doi: medRxiv preprint delirium/confusion), hypoxia at admission (defined as oxygen saturation < 92%), admission to intensive care unit (ICU) at time of sample collection, use of exogenous oxygen during stay, prone position, receiving steroids for treatment on day of sampling, room type (regular private room or negative pressure room), and the presence or absence of a PCR-positive NP swab on or after environmental sampling date (PCR-positive NP swabs were further categorized to Ct>30 and Ct≤30); the sampling date refers to the date the sample was taken. If use of exogenous oxygen during stay was significant, oxygen delivery methods (intubation, facemask/nasal prong, high flow) were included to investigate individual oxygen requirements. Since samples were taken serially from each patient over the course of this study, we included onset of illness to sample date as a fixed-effect control to account for temporal variability. See

Supplementary Table 2 for further variable details. The outcome of interest was SARS-CoV-2 PCRpositive environmental surface samples.

A causal diagram was constructed to examine possible confounding and intervening relationships among exploratory variables relative to a SARS-CoV-2 PCR-positive environmental surface sample. Mixedeffects logistic regression models with a random intercept for unique patient identification to account for clustering were constructed using backwards elimination. Variables that were significant, potential confounders, part of a significant interaction term, or a control variable (i.e. onset of illness to sample date) were included in the final model.

Pearson and deviance residuals were explored for outlying observations. Model fit was assessed by determining if the best linear unbiased predictors (BLUPs) met the assumptions of normality and homogeneity of variance.

The funders had no role in study design, data collection, data analysis, data interpretation, or manuscript preparation.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 20, 2021. ; https://doi.org/10.1101/2021.05.17.21257122 doi: medRxiv preprint

There were 78 inpatients with COVID-19 who consented to participate. All were confirmed to have COVID-19 with a positive nasal, mid-turbinate, or NP swab tested in a licensed diagnostic laboratory in Toronto prior to enrollment; diagnostic samples used for initial COVID-19 confirmation were not included in the present study. Patients were de-identified and randomly assigned a number from 1-78. 

A total of 219 follow-up NP swabs were collected. The median number of NP swabs collected per patient was two (IQR 1-4). Overall, 172 (79%) NP swabs from 74 (95%) patients were positive for SARS-CoV-2 by PCR (Table 2 ). Among patients with at least one positive NP swab, the median number of positive swabs was two (IQR 1-3). The median time between onset of illness and sampling date for PCR-positive swabs was 12 days (IQR 8-17; range 3-52 days).

The median Ct value among positive follow-up NP swabs was 31·4 (IQR 26·8-34·5) ( Figure 1 ). Overall, 30 (27%) of the 110 cultured NP swabs from 21 unique patients yielded viable virus; the highest Ct observed to yield viable virus was 27·2. The median time between onset of illness and sampling date for swabs that yielded viable virus was seven days (IQR 5-11; range 18 days) (Figure 2 ).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 20, 2021. ; https://doi.org/10.1101/2021.05.17.21257122 doi: medRxiv preprint A total of 474 surface samples were collected. Sixty-one patients (78%) had at least one complete set of surface samples, 12 (15%) had four of five surface types, two (3%) had three, and three (4%) had two.

The median duration between onset of illness and surface sample date was ten days (IQR 6-12). The median time between onset of illness and surface sample date for PCR-positive environmental surface samples was nine days (IQR 5-12; range 3-20 days). Overall, 125 (25%) surface samples from 42 (54%) patient rooms yielded SARS-CoV-2 RNA; virus was most frequently detected from the bedrail/ light switch pool and least frequently on the bathroom doorknob ( Table 2 ).

The median Ct value of surface samples testing positive for SARS-CoV2-2 was 33·3 (IQR 29·4-36·0).

Cycle thresholds across surface types were similar ( Figure 1 ). Forty-two surface samples had Ct values <34·0 and six of these (14%), from three (4%) patients, yielded infectious virus; the highest Ct of a sample yielding virus by culture was 29·1 (Figure 2) . Viable virus was recovered from each surface type investigated. 

In total, 152 surface samples and NP swabs with Ct values ranging from 16·3 to 33·2 (UTR gene) underwent whole genome sequencing for SARS-CoV-2. Fifty passed the CanCOGeN (Canadian COVID Genomics Network) quality control for public release of SARS-CoV-2 genomes and were submitted to . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 20, 2021. ; https://doi.org/10.1101/2021.05.17.21257122 doi: medRxiv preprint GSAID; 24 23 of these were from surface samples. Air samples were excluded from the analyses due to poor quality sequences. A phylogenetic analysis of NP and surface swabs is presented in Figure 3 . 

In the final multivariable mixed-effects model, the following were found to be associated with the detection of SARS-CoV-2 RNA in environmental samples: hypoxia on admission, PCR-positive NP swab with Ct ≤ 30 on or after the environmental sampling date, higher Charlson comorbidity index score, and shorter time from onset of illness to environmental sample date ( Table 3 ).

The intraclass correlation coefficient between observations at the patient level was 53% (95% CI: 34-70%). No outlying observations were identified. Graphical exploration of the BLUPs for patient ID appeared to meet the assumptions of homogeneity of variance and normality.

In this prospective cohort study in Ontario, Canada, SARS-CoV-2 RNA was detected from surfaces (25%) and air (2%) in the acute care setting. Although direct comparison of our results to other studies is limited due to heterogeneity in sampling, processing and detection methodologies, proportionally higher . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In the multivariable analysis, hypoxia on admission, a PCR-positive NP swab with a Ct of ≤ 30 on or after the environmental sampling date, higher Charlson co-morbidity index score, and shorter time from . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 20, 2021. ; https://doi.org/10.1101/2021.05.17.21257122 doi: medRxiv preprint symptom onset to environmental sampling were significantly associated with the detection of SARS-CoV-2 RNA in environmental surface samples (Table 3) . Although, to our knowledge, no other study has investigated putative patient factors associated with environmental contamination using multi-variable modelling, our findings are consistent with several observational studies that show that viral load peaks in the first week of illness in COVID-19 patients, with active viral replication in the upper respiratory tract in the first five days of illness. 1, 10, 27, 28 Additionally, both hypoxia and a high Charlson comorbidity index have previously been found to be associated with higher SARS-CoV-2 viral loads in the nasopharynx. 29, 30 Our study has several limitations. First, although we had a large number of surface and air samples, the samples were recovered from only 78 patients, resulting in a relatively small effective sample size when accounting for clustering. While this still facilitated an exploratory analysis, this limited the power of our multivariable analysis as indicated by the wide confidence intervals for some of the significant variables in our final model. The small effective sample size also prohibited us from investigating factors associated with viable virus in environmental surface samples, including time from symptom onset.

Second, the present work focused only on acute care inpatients, excluded critically ill individuals, and had first samples obtained several days after onset of illness. Working in acute care allowed us ready access to patient areas for sampling and clinical data to garner a granular understanding of environmental contamination in hospital settings, the generalizability of our findings to other settings is limited, particularly where room ventilation is highly variable such as homes, schools, long-term care residences, other workplaces, and public spaces. Additionally, it is important to note that these data were collected prior to the emergence of the SARS-CoV-2 variants of concern (VOCs) in late 2020. As such, it is unclear how our results apply to the transmission dynamics of VOCs. Finally, we did not use a standard curve for our RT-PCR analysis and could not calculate the virus concentration per volume of air. Therefore, we were not able to estimate a limit of detection for our aerosol samples.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 20, 2021. ; https://doi.org/10.1101/2021.05.17.21257122 doi: medRxiv preprint

The findings of this study provide insights into surface and air contamination with SARS-CoV-2 in hospitalized COVID-19 patients. We found that SARS-CoV-2 RNA was detected on a minority of surfaces in COVID-19 patients' rooms and rarely from air samples, suggesting these sources are unlikely to pose a major exposure risk in hospitals with similar surface decontamination procedures and ventilation in place. Additionally, hypoxia on admission, PCR-positive NP swab on or after sampling date, comorbidities, and time since symptom onset were found to be important factors associated with the detection of SARS-CoV-2 RNA in the environment. These findings suggest that while early detection and isolation of COVID-19 patients are important, air and surfaces may pose limited risk a few days after admission to acute care hospitals.

This study was conceived, designed, and supervised by AJM and SM. Air sampling protocols were . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 20, 2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 2 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 20, 2021. ; https://doi.org/10.1101/2021.05.17.21257122 doi: medRxiv preprint Figure 3 . Phylogenetic tree of 15 SARS-CoV-2 genomes from inpatients' nasopharyngeal swabs and environmental surface swabs from 10 patients' rooms. Augur pipeline from Nextstain was used to build the phylogenetic tree based on the IQTREE method. The root of the tree is obtained with the first isolate from Wuhan-Hu-1 referenced MN908947·3 in NCBI. The tree is refined using RAxML.

3 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 20, 2021. ; https://doi.org/10.1101/2021.05.17.21257122 doi: medRxiv preprint

Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London

Hospital-acquired SARS-CoV-2 infection: lessons for public health

Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients

Severe Acute Respiratory Syndrome Coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit

Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

Air, surface environmental, and personal protective equipment contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from a symptomatic patient

SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital

Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019

Environmental contamination of SARS-CoV-2 in healthcare premises

Assessment of air contamination by SARS-CoV-2 in hospital settings

Contamination of air and surfaces in workplaces with SARS-CoV-2 virus: a systematic review

Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands

High-throughput SARS-CoV-2 and host genome sequencing from single nasopharyngeal swabs

A Comparison of whole genome sequencing of SARS-CoV-2 using amplicon-based sequencing, random hexamers, and bait capture

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

How to obtain a nasopharyngeal swab specimen

Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

A global clinical measure of fitness and frailty in elderly people

Global initiative on sharing all influenza data -from vision to reality